Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.77
-0.32 (-3.47%)
Nov 21, 2024, 10:44 AM EST - Market open
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 145 employees as of September 30, 2023. The number of employees decreased by 15 or -9.38% compared to the previous year.
Employees
145
Change (1Y)
-15
Growth (1Y)
-9.38%
Revenue / Employee
$496,276
Profits / Employee
-$795,372
Market Cap
186.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Amarin Corporation | 275 |
ADC Therapeutics | 274 |
Inhibrx Biosciences | 172 |
Profound Medical | 131 |
Solid Biosciences | 88 |
XBiotech | 82 |
Acrivon Therapeutics | 61 |
ENTA News
- 2 months ago - Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) - Business Wire
- 2 months ago - Enanta Pharmaceuticals to Participate in Investor Conferences in September - Business Wire
- 3 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter - Business Wire
- 6 months ago - Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference - Business Wire
- 7 months ago - Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference - Business Wire
- 7 months ago - Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET - Business Wire
- 7 months ago - Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire